NIH VideoCast - Novel Omega-3 Mediators & Mechanisms in the Resolution of Inflammation: What Can they Tell us About Preventative and Therapeutic Approaches?

Skip Navigation

Novel Omega-3 Mediators & Mechanisms in the Resolution of Inflammation: What Can they Tell us About Preventative and Therapeutic Approaches?

0 seconds of 0 secondsVolume 90%

00:25

00:00

00:00

493 Views

Air date:	Tuesday, March 13, 2012, 2:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 493 (1 Live, 492 On-demand)
Category:	Stars in Nutrition and Cancer
Runtime:	01:06:33
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Stars in Nutrition and Cancer Objectives Define the functional differences between anti-inflammation versus pro-resolution and the cell types involved; Define the anti-inflammatory and pro-resolving lipid mediators; Review the biosynthesis and omega-3 precursors (EPA and DHA) of the resolvins, protectins and maresins (E-series vs. D-series resolvins) and their actions; Define the resolution indices: what enhances resolution and the drugs that are resolution toxic; and What are the key cellular targets of the resolvins and mechanism(s) (e.g. receptors, miR, etc.) that define resolving autacoids in animal inflammatory diseases. For more information go to http://prevention.cancer.gov/news-events/events/20120313

NLM Title:	Novel omega-3 mediators & mechanisms in the resolution of inflammation : what can they tell us about preventative and therapeutic approaches? / Charles N. Serhan.
Author:	Serhan, Charles N. National Institutes of Health (U.S.)
Publisher:
Abstract:	(CIT): Stars in Nutrition and Cancer Objectives Define the functional differences between anti-inflammation versus pro-resolution and the cell types involved; Define the anti-inflammatory and pro-resolving lipid mediators; Review the biosynthesis and omega-3 precursors (EPA and DHA) of the resolvins, protectins and maresins (E-series vs. D-series resolvins) and their actions; Define the resolution indices: what enhances resolution and the drugs that are resolution toxic; and What are the key cellular targets of the resolvins and mechanism(s) (e.g. receptors, miR, etc.) that define resolving autacoids in animal inflammatory diseases. For more information go to http://prevention.cancer.gov/news-events/events/20120313.
Subjects:	Fatty Acids, Omega-3--therapeutic use Inflammation Mediators--immunology Neoplasms--prevention & control
Publication Types:	Lecture Webcast
NLM Classification:	WB 425
NLM ID:	101581487
CIT Live ID:	11050
Permanent link:	https://videocast.nih.gov/watch=11050

Related Videos...